Precision Genome Editing towards the Treatment of Hemoglobinopathies

Huimeng Sun

2022

Abstract

Hemoglobinopathies, including sickle cell disease and ß – thalassemia, are genetic disorders that cause people to suffer from anemia. Apart from the lifelong therapeutic methods, gene therapy has been introduced in the last decades of research as an efficacious treatment option, supported by various types of delivery methods. In this work, I review the precision genome editing towards the treatment of hemoglobinopathies. With a brief cover of the disease pathology and genome editing tools, special focus has been directed towards the potential editing sites and clinical trials in progress.

Paper Citation

in Harvard Style

Sun H. (2022). Precision Genome Editing towards the Treatment of Hemoglobinopathies. In Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB, ISBN 978-989-758-595-1, pages 1065-1075. DOI: 10.5220/0011377400003443

in Bibtex Style

@conference{icbeb22,
author={Huimeng Sun},
title={Precision Genome Editing towards the Treatment of Hemoglobinopathies},
booktitle={Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB,},
year={2022},
pages={1065-1075},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0011377400003443},
isbn={978-989-758-595-1},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 4th International Conference on Biomedical Engineering and Bioinformatics - Volume 1: ICBEB,
TI - Precision Genome Editing towards the Treatment of Hemoglobinopathies
SN - 978-989-758-595-1
AU - Sun H.
PY - 2022
SP - 1065
EP - 1075
DO - 10.5220/0011377400003443